A multicentre, prospective, controlled, clinical study to evaluate the impact of a synchronous treatment of the anterior accessory saphenous vein for prevention of recurrent varicose veins in patients undergoing thermal ablation of an insufficient great saphenous vein

A multicentre, prospective, controlled, clinical study to evaluate the impact of a synchronous treatment of the anterior accessory saphenous vein for prevention of recurrent varicose veins in patients undergoing thermal ablation of an insufficient great saphenous vein - SYNCHRONOUS-Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015486

Enrollment

1000

Registered

2018-12-21

Start date

2019-02-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I83.9

Interventions

Group 1: Synchronous thermal ablation of the anterior accessory saphenous vein (besides thermal ablation of the great saphenous vein) according to the routine medical care of the clinic/outpatient cli

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. varicose veins (CEAP classification of C2) 2. Patients scheduled for thermal Ablation of a refluxing great saphenous vein 3. Patients = 18 years of age 4. Written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Great saphenous vein unsuitable for endovenous treatment 2. Patients with an incompetent anterior accessory saphenous vein

Design outcomes

Primary

Measure	Time frame
Rate of postoperative recurrent varicose (up to 5 years after the procedure)	—

Secondary

Measure	Time frame
complication rate, post-operative pain intensity, duration of absence from work and normal activity, disease-specific quality of life and patient satisfaction (up to 5 years after the procedure)	—

Countries

Germany

Contacts

Public ContactChristine Fink

Universitätsklinik HeidelbergHautklinik

christine.fink@med.uni-heidelberg.de062215685133

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026